• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » UPS to acquire Polish healthcare logistics company Poltraf

UPS to acquire Polish healthcare logistics company Poltraf

January 5, 2015
CenterWatch Staff

UPS has agreed to terms with Poland-based investment fund ORTIE to acquire its pharmaceutical logistics company Poltraf. The acquisition will further strengthen UPS' healthcare experience and network in Europe, enabling compliant logistics services to customers for streamlining their product supply to the fast-growing healthcare markets of Central and Eastern Europe.

UPS expects to complete the transaction in the first half of 2015, subject to customary closing conditions. Terms of the deal have not been disclosed.

Based in Blonie near Warsaw, Poltraf has offered customers top-rate healthcare logistics solutions for the past nine years. The company is recognized for its temperature-sensitive warehousing and transportation solutions that help healthcare and life sciences companies maximise supply chain efficiencies, meet regulatory requirements and deliver products reliably and securely.

"This acquisition brings greater capability to our global healthcare network," said Cindy Miller, president, UPS Europe. "Poltraf complements our mainland Europe expansion plan and we now are able to provide healthcare companies access to a single source for logistics solutions across the continent, helping to achieve greater supply chain efficiencies and compliance with relevant guidelines."

"This is a very positive development for our company, our employees and our customers," said Piotr Krol, CEO of Poltraf. "Joining forces with UPS will allow us to continue to provide high-quality logistics services to our customers and broaden our reach by leveraging UPS' global distribution network."

The acquisition will add three facilities with advanced warehousing management systems, full quality assurance services and an experienced workforce to UPS' existing European healthcare network, now totaling 14 healthcare facilities. UPS' healthcare reach in Europe now includes dedicated healthcare distribution centers in the Benelux area, Eastern Europe, Central Europe, Southern Europe, the Iberian Peninsula and the U.K., effectively covering Europe's most vital geographies.

Poltraf utilizes a fleet of approximately 170 temperature-controlled vehicles for the transportation of both 2-8 degrees C refrigerated and 15-25 degrees C products. All vehicles feature an end-to-end GPS and temperature-monitoring system, and deliveries are supported by an advanced scan-based tracking program. In addition, 10 field stocking locations, strategically placed across the country, support the timely delivery of the pharmaceuticals and medical devices.

The announcement follows UPS's acquisitions of U.K.-based healthcare logistics innovator Polar Speed, in February 2014; Hungary-based pharmaceutical logistics company CEMELOG, in 2013; and Italy-based Pieffe, in 2011—all part of UPS's ongoing strategy to expand its footprint in vital markets to meet the demands of healthcare customers.

Upcoming Events

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing